Jasmine R. Elison , MD - LSUHSC School of Medicine

	Departments & Centers \| Contact \| Donate
School of Allied Health Professions School of Dentistry School of Graduate Studies School of Medicine School of Nursing School of Public Health LSU Faculty Practice

Administration	Basic Sciences	Clinical Sciences	Centers of Excellence
Admissions Alumni Affairs Community and Minority Health Education Computer Support Continuing Education Dean's Office Faculty & Institutional Affairs Fiscal Affairs Libraries Medical Education Research Student Affairs	Biochemistry & Molecular Biology Cell Biology & Anatomy Genetics Microbiology, Immunology & Parasitology Pharmacology Physiology	Anesthesiology Dermatology Family Medicine Internal Medicine Neurology Neurosurgery OB/GYN Ophthalmology Orthopaedics Otorhinolaryngology Pathology Pediatrics Psychiatry Radiology Surgery Urology	Alcohol and Drug Abuse Center Cardiovascular Center Center for Molecular and Human Genetics Center on Aging Epilepsy Center Eye Center Ernest N. Morial Asthma, Allergy, and Respiratory Disease Center Gene Therapy Program Low Vision Center Neurosciences Center The Research Institute For Children Stanley S. Scott Cancer Center

Patient Care

Education

Research

About Us

Home

LSU Eye Center

	Jasmine R. Elison , MD Assistant Professor of Ophthalmology - Clinical Vitreo-Retinal Medicine and Surgery Academic Office: Department of Ophthalmology 2020 Gravier St. Suite B New Orleans, LA 70112 Phone (office): (504) 568-2081 Fax: (504) 568-2385 Email: jeliso@lsuhsc.edu Patient/Clinical Office: LSU Eye Center 2820 Napoleon Ave. Suite 700 New Orleans LA 70115 Phone: (504) 412-1210 Fax: (504) 899-2866
Degrees	Cornell University; BA (1994) Georgetown University School of Medicine; MD (2000)
Bio	National Cancer Institute/National Institutes of Health (NCI/NIH) Pre-Intra-mural Research Training Award Fellowship (1994 - 1996) Internship: Internal Medicine, Mount Sinai Hospital, New York, NY (2000 - 2001) Residency: Ophthalmology, Mount Sinai Hospital, New York, NY (2001 - 2004) Fellowship: Medical and Surgical Retina, Cornell University/ New York Hospital (2004 - 2006) Retina Medical Staff at Yale-New Haven Hospital (2006 - 2007) Associate, New England Retina Associates (2006 - 2007) Dr. Jasmine Elison is a board-certified ophthalmologist who specializes in the diseases and surgery of the vitreous and retina. She sees patients at the Napoleon Avenue Building in the Ochsner/Baptist Medical Center. She recently joined the academic practice at LSUHSC. Management of diabetic retinopathy Age-related macular degeneration (AMD) Vascular diseases of the retina Management of retinal detachments
Clinical Interests	Dr. Elison carefully studies new research and scientific breakthroughs to determine if and how they can best used to a patients' advantage. Some of the techniques that are currently used are truly cutting-edge procedures, not yet widely available. In the Napoleon Avenue clinic, fluorescein angiography is used to diagnose retinal abnormalities. They can be diagnosed and treated in the same visit using digital angiography. Using a camera and special computer, the digital imaging system provides immediate access to high resolution images of a patient's ocular tissue without waiting 2-7 days for film development. The images can be reviewed on the computer screen.
Research Interests	Multispectral Imaging Medical Informatics
Teaching Activities	Dr. Elison is the Director of the Medical Student Clerkship for the Department of Ophthalmology.
Additional Info	Dr. Elison was recently recognized by the prestigious Retina Society to receive the fifth annual Raymond Margherio Award in Cape Town South Africa. This international award is given to one vitreo-retinal fellow per year in honor of the best research paper specializing on macular disease and surgery of the retina. She presented new research work on the use of a small molecule inhibitor for retinoblastoma ("Small molecule inhibition of HDM2 leads to p53-mediated cell death in retinoblastoma cells" Archives of Ophthalmology, 2006; 124; 1269 - 75.)In 2006 - 2007, Dr Elison was part of a phase III Lucentis (Genentech) clinical trial, studying the safety and efficacy of this novel VEGF inhibitor for the treatment of wet AMD.